Gastrointestinal Stromal Tumor Overview
Gastrointestinal stromal tumor (GIST) is rare cancer affecting the digestive tract or nearby structures within the abdomen. Itis a sarcoma that arises either from cells called interstitial cells of Cajal (ICCs) or from less differentiated stem cells or precursor cells that can develop into ICCs. GIST progression is driven by mutations in KIT or PDGFRA or by other rare gene alterations, all of which are mutually exclusive. It is known that the majority of tumors of GIST will have mutations in the KITgene, and a minority, in the PDGFR gene.
“Gastrointestinal Stromal Tumor Pipeline Insight, 2022“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Gastrointestinal Stromal Tumor Market.
The Gastrointestinal Stromal Tumor Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Gastrointestinal Stromal Tumor Pipeline Report:
Gastrointestinal Stromal Tumor Pipeline Therapeutics Assessment
DelveInsight’s Gastrointestinal Stromal Tumor Report covers around 28+ products under different phases of clinical development like
Emerging Gastrointestinal Stromal Tumor Drugs Under Different Phases of Clinical Development Include:
Gastrointestinal Stromal Tumor Pipeline Analysis:
The Gastrointestinal Stromal Tumor pipeline report provides insights into
The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Gastrointestinal Stromal Tumor product details are provided in the report. Download the Gastrointestinal Stromal Tumor pipeline report to learn more about the emerging Gastrointestinal Stromal Tumor therapies
Gastrointestinal Stromal Tumor Pipeline Market Drivers
Gastrointestinal Stromal Tumor Pipeline Market Barriers
Get a Free Sample PDF Report to know more about Gastrointestinal Stromal Tumor Pipeline Assessment
Scope of Gastrointestinal Stromal Tumor Pipeline Drug Insight
Request for Sample PDF Report for Gastrointestinal Stromal Tumor Pipeline Assessment and clinical trials
Table of Contents
1
Gastrointestinal Stromal Tumor Report Introduction
2
Gastrointestinal Stromal Tumor Executive Summary
3
4
Gastrointestinal Stromal Tumor- Analytical Perspective In-depth Commercial Assessment
5
Gastrointestinal Stromal Tumor Pipeline Therapeutics
6
Gastrointestinal Stromal Tumor Late Stage Products (Phase II/III)
7
Gastrointestinal Stromal Tumor Mid Stage Products (Phase II)
8
Gastrointestinal Stromal Tumor Early Stage Products (Phase I)
9
Gastrointestinal Stromal Tumor Preclinical Stage Products
10
Gastrointestinal Stromal Tumor Therapeutics Assessment
11
Gastrointestinal Stromal Tumor Inactive Products
12
Company-University Collaborations (Licensing/Partnering) Analysis
13
Gastrointestinal Stromal Tumor Key Companies
14
Gastrointestinal Stromal Tumor Key Products
15
Gastrointestinal Stromal Tumor Unmet Needs
16
Gastrointestinal Stromal Tumor Market Drivers and Barriers
17
Gastrointestinal Stromal Tumor Future Perspectives and Conclusion
18
Gastrointestinal Stromal Tumor Analyst Views
19
Appendix
20
About DelveInsight
Download Sample PDF Report to know more about Gastrointestinal Stromal Tumor drugs and therapies
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Gaurav BoraEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/